---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-23-000270"
form_type: "8-K"
ticker: "STEX"
cik: "0001530766"
company_name: "Streamex Corp."
filed_at: "2023-03-29T23:59:59+00:00"
generated_at: "2026-06-17T10:22:00.540960+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BioSig Technologies raises $1.02M in PIPE offering with warrants

## Summary
- Sold 935,130 shares at $1.0885/share and warrants for 467,565 shares at $1.026.
- Aggregate proceeds of $1,017,889 from accredited investors.
- Warrants exercisable 6 months after issuance, expire 5.5 years from issuance.
- Laidlaw & Company received a warrant for 49,465 shares as compensation.
- Offering exempt from registration under Section 4(a)(2) and Regulation D.

## SEC filing metadata
- accession: 0001185185-23-000270
- form_type: 8-K
- ticker: STEX
- cik: 0001530766
- company_name: Streamex Corp.
- filed_at: 2023-03-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000270/0001185185-23-000270-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000270/biosig20230328_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-23-000270
- JSON: https://secwatch.observer/filing/0001185185-23-000270.json
- Plain text: https://secwatch.observer/filing/0001185185-23-000270.txt

## Key facts
- Material Agreements
  Streamex Corp. entered into Securities Purchase Agreement with certain accredited investors valued at $1,017,889.00 (effective 2023-03-24).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain accredited investors
  - Value: $1,017,889.00
  - Effective: 2023-03-24
  source text: On March 24, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 935,130 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $1.0885 per share, and warrants (the “Warrants”) to purchase up to 467,565 shares of Common Stock (the “Warrant Shares” and together with the Shares and Warrants, the “Securities”), at an exercise price of $1.026 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance, in exchange for aggregate consideration of $1,017,889.00 (the “March PIPE”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000270/0001185185-23-000270-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.